MedPath

Effects of flaxseed consumption in liver cirrhosis

Not Applicable
Not yet recruiting
Conditions
liver cirrhosis.
Fibrosis and cirrhosis of liver
Registration Number
IRCT20230514058189N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

All patients with liver cirrhosis whose cirrhosis has been confirmed by a specialist physician.

Exclusion Criteria

Those who have other extrahepatic diseases at the same time.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of liver cirrhosis according to Model for end stage liver disease score (MELD). Timepoint: Measurement of disease severity based on the MELD score before and 12 weeks after the start of flaxseed powder consumption. Method of measurement: Calculation of MELD using the formula and variables of bilirubin, creatinine and INR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath